Evidence map›Paper›PMID 31380732›Full record

ArticleJournal of addictive diseases

Technology preferences to enhance HIV and HCV care among patients with substance use disorders.

Babak Tofighi, Paul Hein, Alexandre M S Carvalho, Joshua D Lee, Noelle R Leonard

Abstract read
In one paragraph

Article in Journal of addictive diseases. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Babak TofighiDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Paul HeinDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Alexandre M S CarvalhoUniversidade Federal do Rio de Janeiro UFRJ, Rio de Janeiro, Brazil.
Joshua D LeeDepartment of Population Health, New York University School of Medicine, New York, NY, USA.
Noelle R LeonardCenter for Drug Use and HIV Research (CDUHR), New York, NY, USA.

Funding

Transdisciplinary Theoretical Svnthesis and Development CoreP30DA011041 · NIDA · NEW YORK UNIVERSITY · PI Holly Hagan · 1998 to 2026
$38.9M
Development of a text messaging tool to support buprenorphine treatment in primary careK23DA042140 · NIDA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI TOFIGHI, BABAK · 2017 to 2021
$969k
NIDA NIH HHS K23 DA042140NIDA NIH HHS P30 DA011041
6 · The paper itself

Abstract

We examined technology use patterns (e.g., mobile phone and computer ownership, text messaging, internet access) and preferences for adopting health information technologies to optimize office-based treatment for substance use disorders, HIV, and Hepatitis C virus (HCV) infection. Surveys were administered to patients enrolled in inpatient detoxification program in a publicly-funded tertiary referral center. Most reported mobile phone ownership (86%) and described high rates of mobile phone (3.3) and phone number (2.6) turnover in the preceding year. Internet access was reported on a daily (52%) or weekly basis (22%). Most participants were amenable to receiving text message-based informational content (i.e., medications, support groups, treatment programs) pertaining to substance use disorders (79%), HIV (50%), and HCV care (58%). Respondents reporting less than high school education and past year incarcerated elicited higher favorability in adopting smartphone apps to facilitate peer sharing of HIV-HCV related content. Results suggest high favorability for adopting health information technologies to enhance office-based treatment for substance use disorders, HIV, and HCV, particularly among vulnerable patient sub-groups.

Indexed as

Hepatitis CHIVmobile healthOpioid use disordertechnology based intervention

Identifiers

PMID31380732
PMCPMC6946844

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.